Skip to content

Show results to participants engaged in clinical trials

Show RESults to Participants Engaged in Clinical Trials: A cluster randomised factorial trial of different modes of communicating results to participants of the ICON8 phase III ovarian cancer trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN96189403
Enrollment
255
Registered
2019-02-26
Start date
2019-01-07
Completion date
Unknown
Last updated
2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Communicating trial results to participants Not Applicable

Interventions

In Show RESPECT, ICON8 sites will be randomised using 2 by 2 by 2 factorial cluster randomisation. Therefore there will be 8 possible intervention combinations. The interventions within the study are:

Sponsors

University College London
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Participant in the ICON8 trial 2. Currently being followed up at an ICON8 trial site in England, Scotland, Wales and Northern Ireland 2.1. Including those with reduced follow-up arrangements 3. Aged 18 years or older

Exclusion criteria

Exclusion criteria: 1. Participant has previously informed their site that they do not wish to attend any further visits in relation to the ICON8 trial 2. Lost to follow-up from the ICON8 trial 3. Site staff consider the patient to be too unwell to be contacted about this study

Design outcomes

Primary

MeasureTime frame
The primary outcome measure is participant’s satisfaction with the way they found out the results of ICON8, measured using a 5-point Likert scale one month after receiving the intervention.

Secondary

MeasureTime frame
1. The extent of participant’s agreement with the statement ‘the information about the trial results told me everything I wanted to know’, measured using a 5-point Likert scale one month after receiving the intervention. 2. Participants’ Ease of understanding of the results, measured using a 5-point Likert scale one month after receiving the intervention. 3. How upsetting participants found the results, measured using a 5-point Likert scale one month after receiving the intervention. 4. Participants’ willingness to take part in another trial in the future, measured using a 5-point Likert scale one month after receiving the intervention. 5. Participants’ likelihood of recommending taking part in a clinical trial to friends and family, measured using a 5-point Likert scale one month after receiving the intervention. 6. How glad participants are to have found out the results, measured using a 5-point Likert scale one month after receiving the intervention. 7. Participants’ regret at finding out the results, measured using a 5-point Likert scale one month after receiving the intervention. 8. Reported uptake of the interventions offered, measured using self-report via a questionnaire one month after receiving the intervention. 9. Proportion of participants who reported wanting to find out the results but not having done so, measured using a questionnaire one month after receiving the intervention. 10. Proportion of participants who reported not wanting to find out the results who did find out the results, measured using a questionnaire one month after receiving the intervention. 11. Participants’ reported ease of finding out the results, measured using a 5-point Likert scale one month after receiving the intervention. 12. Other ways participants would have liked to receive the result, measured using free-text question in a questionnaire one month after receiving the intervention. 13. Participants preferred way to receive the results, measured using a multiple choice ques

Countries

England, United Kingdom, Wales

Contacts

Public ContactAnnabelle South

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 14, 2026